ID   HGC-25
AC   CVCL_C827
SY   HGC 25
DR   cancercelllines; CVCL_C827
DR   GEO; GSM784700
DR   Progenetix; CVCL_C827
DR   Wikidata; Q54886003
RX   PubMed=851032;
RX   PubMed=3518877;
CC   Population: Japanese.
CC   Doubling time: 15.6 hours (PubMed=851032).
CC   Misspelling: HCG-25; Note=Occasionally.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 12
//
RX   PubMed=851032; DOI=10.1111/j.1440-1827.1977.tb01859.x;
RA   Akagi T., Kimoto T.;
RT   "Establishment and characteristics of a human pancreatic cancer cell
RT   line (HGC-25).";
RL   Acta Pathol. Jpn. 27:51-58(1977).
//
RX   PubMed=3518877; DOI=10.3109/07357908609038260;
RA   Fogh J.;
RT   "Human tumor lines for cancer research.";
RL   Cancer Invest. 4:157-184(1986).
//